Clinical Trial Update: Safety Evaluation of MSC-based Therapy for Liver Cihcrosis Treatment [Phase 1]

View source ↗

Summary

A Phase 1 safety evaluation of a mesenchymal stem cell-based therapy for liver cirrhosis; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Mesenchymal stem cell-based therapy

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Liver Cirrhosis | Phase 1 | Status: NOT_YET_RECRUITING